Skip to Content

FRIDAY, 19 DECEMBER 2025, 15:11

Top Stories

One decision cost South Africa a decade

Today at 15:00 PM, via Daily Investor

South Africa’s “lost decade” was triggered by the 2015 firing of Finance Minister Nhlanhla Nene, which shattered investor confidence and compounded existing governance and policy failures, but analysts now think this era has come to an end.

South Africa

Strategy to combat Foot-and-Mouth Disease strengthened

Today at 14:53 PM, via SAnews

Strategy to combat Foot-and-Mouth Disease strengthened The Minister of Agriculture John Steenhuisen has expressed confidence in South Africa’s intensified strategy to combat Foot-and-Mouth Disease (FMD).“South Africa now has a realistic and technically sound roadmap to realise its goal of FMD-free status with vaccination, a crucial step for restoring confidence in export markets...

Business

Great news about petrol prices in January

Today at 13:00 PM, via BusinessTech

The latest data from the Central Energy Fund (CEF) for the end of the third week in December indicates that motorists can expect an even bigger cut in prices at the pumps.

Sport

Uefa pays £7.8m to clubs for Women’s Euros players

Today at 14:32 PM, via BBC News

Uefa has distributed €9 million (£7.88m) between 103 European clubs as benefit payments for releasing players for Women’s Euro 2025, with Chelsea and Arsenal sharing £763,000

Sport

Gloucester-bound Lake back to lead Ospreys

Today at 14:02 PM, via BBC News

Wales hooker Dewi Lake will return to captain Ospreys for the United Rugby Championship home match against Munster in Bridgend on Saturday.

Education

U.S. Will Pay $450,000 to Wildfire Fighters With Cancer

Today at 12:03 PM, via New York Times

They will be eligible for a one-time payment as well as college tuition for their children. The effort is part of a legislative push to address the dangers of working in toxic smoke.

Health

Why the New Cannabis Classification Matters

Today at 12:04 PM, via New York Times

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses and patients.